Molecular tools to study melatonin pathways and actions

被引:187
作者
Boutin, JA
Audinot, V
Ferry, G
Delagrange, P
机构
[1] Inst Rech Servier, F-78290 Croissy Sur Seine, France
[2] Inst Rech Servier, Dept Sci Expt, F-92150 Suresnes, France
关键词
D O I
10.1016/j.tips.2005.06.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Melatonin, an indoleamine neurohormone that is synthesized mainly in the pineal gland and derived from 5-HT, has many effects on a wide range of physiopathological functions. Some of these effects are mediated by the interactions of melatonin with the two melatonin MT1 and MT2 receptors. Other effects are often suggested to be due to the chemical antioxidant nature of this indoleamine, and are observed at high, non-physiological concentrations. However, it is increasingly believed that some of these effects are due to interactions with other protein targets. In this review, we summarize the molecular pharmacology of melatonin, including the main enzymes involved in its synthesis and catabolism, and the proteins that mediate its actions. Furthermore, various compounds, mainly inhibitors and antagonists, that can be used to dissect these functions and pathways are presented.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 73 条
  • [1] CHARACTERIZATION OF HIGH-AFFINITY MELATONIN BINDING-SITES IN PURIFIED CELL-NUCLEI OF RAT-LIVER
    ACUNACASTROVIEJO, D
    REITER, RJ
    MENENDEZPELAEZ, A
    PABLOS, MI
    BURGOS, A
    [J]. JOURNAL OF PINEAL RESEARCH, 1994, 16 (02) : 100 - 112
  • [2] Mechanism of reaction of melatonin with human myeloperoxidase
    Allegra, M
    Furtmüller, PG
    Regelsberger, G
    Turco-Liveri, ML
    Tesoriere, L
    Perretti, M
    Livrea, RA
    Obinger, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) : 380 - 386
  • [3] Anisimov SV, 2004, REV NEUROSCIENCE, V15, P209
  • [4] New selective ligands of human cloned melatonin MT1 and MT2 receptors
    Audinot, V
    Mailliet, F
    Lahaye-Brasseur, C
    Bonnaud, A
    Le Gall, A
    Amossé, C
    Dromaint, S
    Rodriguez, M
    Nagel, N
    Galizzi, JP
    Malpaux, B
    Guillaumet, G
    Lesieur, D
    Lefoulon, F
    Renard, P
    Delagrange, P
    Boutin, JA
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (06) : 553 - 561
  • [5] Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers
    Ayoub, MA
    Levoye, A
    Delagrange, P
    Jockers, R
    [J]. MOLECULAR PHARMACOLOGY, 2004, 66 (02) : 312 - 321
  • [6] Design, synthesis and in vitro evaluation of novel derivatives as serotonin N-acetyltransferase inhibitors
    Beaurain, N
    Mésangeau, C
    Chavatte, P
    Ferry, G
    Audinot, V
    Boutin, JA
    Delagrange, P
    Bennejean, C
    Yous, S
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (06) : 409 - 414
  • [7] Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily (vol 269, pg 28531, 1994)
    BeckerAndre, M
    Wiesenberg, I
    SchaerenWiemers, N
    Andre, E
    Missbach, M
    Saurat, JH
    Carlberg, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16707 - 16707
  • [8] BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531
  • [9] Quinone reductase 2 substrate specificity and inhibition pharmacology
    Boutin, JA
    Chatelain-Egger, F
    Vella, F
    Delagrange, P
    Ferry, G
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 151 (03) : 213 - 228
  • [10] Combinatorial peptide synthesis: Statistical evaluation of peptide distribution
    Boutin, JA
    Fauchere, AL
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (01) : 8 - 12